Data Gap in Sacral Neuromodulation Documentation: Call to Improve Documentation Protocols

다국어 초록 (Multilingual Abstract)

Purpose: We quantified patient record documentation of sacral neuromodulation (SNM) threshold testing and programming parameters at our institution to identify opportunities to improve therapy outcomes and future SNM technologies.
Methods: A retrospective review was conducted using 127 records from 40 SNM patients. Records were screened for SNM documentation including qualitative and quantitative data. The qualitative covered indirect references to threshold testing and the quantitative included efficacy descriptions and device programming used by the patient. Findings were categorized by visit type: percutaneous nerve evaluation (PNE), stage 1 (S1), permanent lead implantation, stage 2 (S2) permanent impulse generator implantation, device-related follow-up, or surgical removal.
Results: Documentation of threshold testing was more complete during initial implant visits (PNE and S1), less complete for S2 visits, and infrequent for follow-up clinical visits. Surgical motor thresholds were most often referred to using only qualitative comments such as “good response” (88%, 100% for PNE, S1) and less commonly included quantitative values (68%, 84%), locations of response (84%, 83%) or specific contacts used for testing (0%). S2 motor thresholds were less well documented with qualitative, quantitative, and anatomical location outcomes at 70%, 48%, and 36% respectively. Surgical notes did not include specific stimulation parameters or contacts used for tests. Postoperative sensory tests were often only qualitative (80%, 67% for PNE, S1) with quantitative values documented much less frequently (39%, 9%) and typically lacked sensory locations or electrode-specific results. For follow-up visits, <10% included quantitative sensory test outcomes. Few records (<7%) included device program settings recommended for therapy delivery and none included therapy-use logs.
Conclusions: While evidence suggests contact and parameter-specific programming can improve SNM therapy outcomes, there is a major gap in the documentation of this data. More detailed testing and documentation could improve therapeutic options for parameter titration and provide design inputs for future technologies.

참고문헌 (Reference)

• 1 Sam Tilborghs, "The Influence of Electrode Configuration Changes on the Sensory and Motor Response During (Re)Programming in Sacral Neuromodulation" Elsevier BV 25 (25): 1173-1179, 2022
• 2 Vaganée D, "Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation" 123 (123): E7-E13, 2019
• 3 Burks FN, "Sacral neuromodulation reprogramming : is it an office burden" 19 : 1137-1140, 2008
• 4 Guzman-Negron JM, "Sacral neuromodulation lead twisting causes migration and loss of efficacy" 26 : e13-e15, 2020
• 5 Wöllner J, "Sacral neuromodulation : surgery illustrated" 110 : 146-159, 2012
• 6 Matzel KE, "Sacral neuromodulation : standardized electrode placement technique : standardized electrode placement for SNM" 20 : 816-824, 2017
• 7 De Wachter S, "Sacral neuromodulation : mechanism of action" 6 : 823-825, 2020
• 8 Bosch JL, "Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence : long-term results of a prospective longitudinal study" 163 : 1219-1222, 2000
• 9 Dudding TC, "Reprogramming sacral neuromodulation for sub-optimal outcomes : evidence and recommendations for clinical practice" 24 : 1247-1257, 2021
• 10 Vaganée D, "Repeatability of tools to assist in the follow up and troubleshooting of sacral neuromodulation patients using the sensory response" 38 : 801-808, 2019
• 11 Lehur PA, "Programming algorithms for sacral neuromodulation : clinical practice and evidence—recommendations for dayto-day practice" 23 : 1121-1129, 2020
• 12 Cattle KR, "Programming InterStimTM for faecal incontinence" 11 : 485-488, 2009
• 13 Peters KM, "Predictors of reoperation after sacral neuromodulation : a single institution evaluation of over 400 patients" 36 : 354-359, 2017
• 14 "Planning an outpatient procedure? [Internet]"
• 15 Ammirati E, "Neuromodulation in urology, state of the art" 86 : 177-182, 2019
• 16 Goldman HB, "International Continence Society best practice statement for use of sacral neuromodulation" 37 : 1823-1848, 2018
• 17 Deng DY, "Failure of sacral nerve stimulation due to migration of tined lead" 175 : 2182-2185, 2006
• 18 Snellings AE, "Effects of stimulation site and stimulation parameters on bladder inhibition by electrical nerve stimulation" 110 : 136-143, 2012
• 19 Lee J, "Comparison of motor and sensory response of InterStim® for overactive bladder syndrome" 19 : 317-321, 2013
• 20 Zirpel L, "AB291. SPR-18 Correlation of sacral nerve lead targeting and urological efficacy: motor mapping, electrode position, and stimulation amplitude" 5 (5): AB291-, 2016